US Patent Issued to UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH on Oct. 14 for "Treatment for ocular fibrosis" (Texas Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,538, issued on Oct. 14, was assigned to UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH (Fort Worth, Texas).

"Treatment for ocular fibrosis" was invented by Dimitrios Karamichos (Carrollton, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes methods of treating ocular fibrosis of the eye in a human subject, the method comprising administering to the human subject in need of treatment a therapeutically effective amount of a prolactin-inducible Protein (PIP) which is capable of inhibiting or reversing the ocular fibrosis."

The patent was filed on April 7, 2023, under Application No. 18/853,789.

*For fur...